ANDA 73444, held by Watson Labs. Meperidine Hydrochloride.
As of Nov 16, 2026, ANDA 73444 (Meperidine Hydrochloride), held by Watson Labs, was first approved by FDA on Mar 17, 1992, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 17, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Meperidine Hydrochloride50MG/ML ยท injectable;injection | Meperidine Hydrochloride | Discontinued |
| Feb 19, 1999 | Supplement 8Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 5Manufacturing | Approved | None posted |
| Dec 4, 1996 | Supplement 4Manufacturing | Approved | None posted |
| Aug 18, 1995 | Supplement 2Labeling | Approved | None posted |
| Aug 18, 1995 | Supplement 3Manufacturing | Approved | None posted |
| Jul 12, 1995 | Supplement 1Manufacturing | Approved | None posted |
| Mar 17, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters